TickerFacts.

A business in context

NVS research notebook

Read the disclosures. Follow the relationships. Keep the dates in view.

Research JSON

Filing timeline

Download filings CSV

SEC submissions · retrieved 2026-09-08 · 8005 issuers; up to 32 recent company reports and 8 ownership-change filings per issuer

  1. 6-K · Current report

    Report date 2026-09-04 · 0001171843-26-005896

  2. 6-K · Current report

    Report date 2026-09-01 · 0001171843-26-005824

  3. 6-K · Current report

    Report date 2026-06-30 · 0001114448-26-000012

  4. 6-K · Current report

    Report date 2026-06-11 · 0001171843-26-004052

  5. 6-K · Current report

    Report date 2026-03-31 · 0001114448-26-000010

  6. 6-K · Current report

    Report date 2026-03-18 · 0001104659-26-031037

  7. 6-K · Current report

    Report date 2025-12-31 · 0001114448-26-000008

  8. 6-K · Current report

    Report date 2025-12-31 · 0001114448-26-000007

  9. 20-F · Annual report

    Report date 2025-12-31 · 0001114448-26-000004

  10. 6-K · Current report

    Report date 2025-11-24 · 0001171843-25-007547

  11. 6-K · Current report

    Report date 2025-11-20 · 0001171843-25-007445

  12. 6-K · Current report

    Report date 2025-11-05 · 0001104659-25-107058

  13. 6-K · Current report

    Report date 2025-09-30 · 0001114448-25-000003

  14. 6-K · Current report

    Report date 2025-10-27 · 0001171843-25-006660

  15. 6-K · Current report

    Report date 2025-09-30 · 0001171843-25-006196

  16. 6-K · Current report

    Report date 2025-08-11 · 0001171843-25-005290

  17. 6-K · Current report

    Report date 2025-06-30 · 0001370368-25-000012

  18. 6-K · Current report

    Report date 2025-07-17 · 0001171843-25-004531

  19. 6-K · Current report

    Report date 2025-04-03 · 0001171843-25-003556

  20. 6-K · Current report

    Report date 2025-03-31 · 0001370368-25-000010

  21. 6-K · Current report

    Report date 2025-04-03 · 0001171843-25-001979

  22. 6-K · Current report

    Report date 2025-03-28 · 0001171843-25-001805

  23. 6-K · Current report

    Report date 2024-12-31 · 0001370368-25-000008

  24. 6-K · Current report

    Report date 2024-12-31 · 0001370368-25-000007

  25. 20-F · Annual report

    Report date 2024-12-31 · 0001370368-25-000004

  26. 6-K · Current report

    Report date 2024-12-30 · 0001171843-24-007096

  27. 6-K · Current report

    Report date 2024-11-21 · 0001171843-24-006547

  28. 6-K · Current report

    Report date 2024-09-30 · 0001370368-24-000022

  29. 6-K · Current report

    Report date 2024-10-29 · 0001171843-24-005855

  30. SC 13D/A · Ownership disclosure

    0001104659-24-109522

  31. 6-K · Current report

    Report date 2024-09-18 · 0001104659-24-100991

  32. 6-K · Current report

    Report date 2024-09-17 · 0001171843-24-005228

  33. 4 · Ownership change

    Report date 2020-07-14 · 0001104659-20-084106

  34. 4 · Ownership change

    Report date 2020-06-30 · 0001104659-20-080559

  35. 4 · Ownership change

    Report date 2020-06-18 · 0000925421-20-000256

  36. 4 · Ownership change

    Report date 2020-06-15 · 0000925421-20-000254

  37. 4 · Ownership change

    Report date 2020-06-10 · 0000925421-20-000248

  38. 4 · Ownership change

    Report date 2020-06-05 · 0000925421-20-000244

  39. 4 · Ownership change

    Report date 2020-06-02 · 0000925421-20-000228

  40. 4 · Ownership change

    Report date 2019-11-12 · 0000899243-19-027115

Reported insider transactions

Download transactions CSV

SEC insider transactions · retrieved 2026-09-07 · 2026 Q2: filings in this completed quarter; not a live transaction feed

Purchases and sales include open-market or private transactions. Grants, exercises and tax withholding are shown separately. Amendments and joint reports can overlap; rows are not a net-buying score. Prices retain the filing's units; consult its footnotes.

Transaction rows by code · counts, not monetary totals
Purchase: 0 transaction rows0PSale: 0 transaction rows0SGrant / award: 0 transaction rows0AExercise / conversion: 0 transaction rows0MTax / exercise payment: 0 transaction rows0FGift: 0 transaction rows0G
P · PurchaseS · SaleA · Grant / awardM · Exercise / conversionF · Tax / exercise paymentG · Gift

0 matching transaction rows.

No matching transaction rows in the covered quarter. This does not establish that no insider transactions occurred.

Identity & relationships

Wikidata structured data · retrieved 2026-09-07 · 1611 unambiguous CIK-linked entities; coverage is incomplete

These are sourced identity and relationship claims, with incomplete coverage. Headquarters locations do not describe sales, assets or operating exposure.

SEC issuer · 0001114448NOVARTIS AG
NovartisChiron CorporationNovartis (Singapore)Novartis (France)Novartis (Japan)Novartis (United Kingdom)Novartis Healthcare (India)Novartis (Italy)Novartis (Canada)Novartis (Slovenia)Novartis (Netherlands)Novartis (Austria)Novartis (China)Novartis (Germany)Novartis (Mexico)Novartis Baltics, SIA

Showing 16 of 16 imported Wikidata subsidiary claims. Additional aliases appear below.

No parent relationship is available in this import; this is not proof of independence.

Legal Entity Identifier
5493007HIVTX6SY6XD66
GLEIF legal name
NOVARTIS AG
Entity / LEI registration status
ACTIVE / ISSUED
Reference data updated
2025-11-03T08:07:00Z

direct-parent: no parent LEI supplied

ultimate-parent: no parent LEI supplied

GLEIF legal entity reference data · retrieved 2026-09-07 · 1177 checked identities; 0 unavailable records

Search names and former names

View Wikidata identity and references ↗

  • Novartis · subsidiary · wikidata
  • Novartis International AG · alias · wikidata
  • Chiron Corporation · subsidiary · wikidata
  • Novartis (Singapore) · subsidiary · wikidata
  • Novartis (France) · subsidiary · wikidata
  • Novartis (Japan) · subsidiary · wikidata
  • Novartis (United Kingdom) · subsidiary · wikidata
  • Novartis Healthcare (India) · subsidiary · wikidata
  • Novartis (Italy) · subsidiary · wikidata
  • Novartis (Canada) · subsidiary · wikidata
  • Novartis (Slovenia) · subsidiary · wikidata
  • Novartis (Netherlands) · subsidiary · wikidata
  • Novartis Pharma · subsidiary · wikidata
  • Novartis (Austria) · subsidiary · wikidata
  • Novartis (China) · subsidiary · wikidata
  • Novartis (Germany) · subsidiary · wikidata
  • Novartis (Mexico) · subsidiary · wikidata
  • Novartis Baltics, SIA · subsidiary · wikidata
  • Novartis (Latvia) · subsidiary · wikidata
  • Novartis s.r.o. · subsidiary · wikidata
Explore headquarters map ↗

Revenue in constant purchasing power

USD revenue expressed in 2026-07 consumer-price dollars. Each annual period uses a CPI-U average weighted by the days in its actual reporting interval. This is a purchasing-power comparison, not a company-specific price or volume measure.

No USD annual revenue periods with complete CPI coverage are available. Non-USD statements are not converted with U.S. CPI.

Bureau of Labor Statistics · retrieved 2026-09-08 · 9 selected series; gaps remain missing

Explore the CPI history ↗